Amgen’s Tavneos discouraged by Japanese partner after deaths

AI Summary

Amgen’s drug Tavneos is under scrutiny following reports of 20 deaths in Japan, although it remains unclear whether the drug was directly responsible. This situation raises concerns about drug safety and regulatory oversight in the healthcare sector.

Twenty people in Japan died after taking Tavneos, though it's unclear whether the drug killed those people, a media report said.